Integra Lifesciences Holdings (IART) Non-Current Assets (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Non-Current Assets data on file, last reported at $2.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 18.33% year-over-year to $2.4 billion; the trailing twelve-month figure through Mar 2026 stood at $9.9 billion (down 16.51% YoY), and the FY2025 full-year result was $2.4 billion, down 17.37% from the prior year.
• Non-Current Assets slipped to $2.4 billion in Q1 2026, from $2.4 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $3.0 billion in Q3 2024 to a low of $2.4 billion in Q1 2026.
• A 5-year average of $2.7 billion and a median of $2.7 billion in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets grew 10.63% in 2025 and slipped 18.33% in 2026, its largest moves.
• Tracing IART's Non-Current Assets over 5 years: stood at $2.7 billion in 2022, then decreased by 0.16% to $2.7 billion in 2023, then gained by 8.51% to $3.0 billion in 2024, then slipped by 17.37% to $2.4 billion in 2025, then dropped by 1.5% to $2.4 billion in 2026.
• Business Quant data shows IART's Non-Current Assets at $2.4 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.5 billion in Q3 2025.